SC Pharmaceuticals Inc (SCPH)
2.33 x 2 2.57 x 1
Post-market by (Cboe BZX)
2.33 -0.30 (-11.41%) 04/01/25 [NASDAQ]
2.33 x 2 2.57 x 1
Post-market 2.42 +0.09 (+3.86%) 16:21 ET
for Tue, Apr 1st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Sales | 12,150 | 10,026 | 8,054 | 6,102 | 6,096 |
Cost of Goods | 3,965 | 3,311 | 2,300 | 1,785 | 1,773 |
Gross Profit | 8,185 | 6,715 | 5,754 | 4,317 | 4,323 |
Operating Expenses | 25,493 | 25,172 | 20,485 | 20,958 | 20,353 |
Operating Income | -16,343 | -18,146 | -14,431 | -15,856 | -15,257 |
Interest Expense | 1,485 | 1,850 | 2,134 | 2,101 | 2,092 |
Other Income | -1,017 | -15,109 | -525 | 3,849 | 3,537 |
Pre-tax Income | -18,845 | -35,105 | -17,090 | -14,108 | -13,812 |
Net Income Continuous | -18,845 | -35,105 | -17,090 | -14,108 | -13,812 |
Net Income | $-18,845 | $-35,105 | $-17,090 | $-14,108 | $-13,812 |
EPS Basic Total Ops | -0.36 | -0.75 | -0.44 | -0.36 | -0.35 |
EPS Basic Continuous Ops | -0.36 | -0.75 | -0.44 | -0.36 | -0.36 |
EPS Diluted Total Ops | -0.36 | -0.75 | -0.44 | -0.36 | -0.35 |
EPS Diluted Continuous Ops | -0.36 | -0.75 | -0.44 | -0.36 | -0.36 |
EPS Diluted Before Non-Recurring Items | N/A | -0.37 | -0.44 | -0.36 | -0.35 |
EBITDA(a) | $-16,339 | $-18,233 | $-14,379 | $-15,805 | $-15,251 |